HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,596,143 | -25.6% | 25,790 | -4.1% | 0.07% | -22.7% |
| Q2 2022 | $2,144,746 | -26.1% | 26,890 | -2.6% | 0.09% | -11.1% |
| Q1 2022 | $2,903,165 | +19.6% | 27,594 | +22.5% | 0.10% | +20.7% |
| Q4 2021 | $2,427,833 | +4.6% | 22,530 | +6.4% | 0.08% | -5.7% |
| Q3 2021 | $2,320,495 | +19.8% | 21,184 | +2.4% | 0.09% | +16.0% |
| Q2 2021 | $1,937,412 | +2.4% | 20,690 | +0.7% | 0.08% | -9.6% |
| Q1 2021 | $1,891,790 | +28.3% | 20,554 | +2.0% | 0.08% | +10.7% |
| Q4 2020 | $1,474,338 | -5.8% | 20,155 | +0.0% | 0.08% | -16.7% |
| Q3 2020 | $1,565,019 | +40.1% | 20,147 | +0.3% | 0.09% | +23.3% |
| Q2 2020 | $1,116,825 | +116.3% | 20,094 | +15.3% | 0.07% | +69.8% |
| Q1 2020 | $516,306 | -19.1% | 17,431 | -1.2% | 0.04% | -4.4% |
| Q4 2019 | $638,387 | +30.9% | 17,635 | -1.5% | 0.04% | +12.5% |
| Q3 2019 | $487,662 | +8.5% | 17,909 | -4.1% | 0.04% | +5.3% |
| Q2 2019 | $449,321 | – | 18,675 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |